Matches in DBpedia 2014 for { ?s ?p Elobixibat is an IBAT inhibitor, in clinical testing as of December 2012 for the treatment of chronic constipation and irritable bowel syndrome with constipation (IBS-C). It works by blocking the enterohepatic circulation of bile acids, increasing the bile acid concentration in the gut, which accelerates intestinal passage and softens the stool.The drug was developed by Albireo AB, who licensed it to Ferring Pharmaceuticals for further development and marketing.Albireo has partnered with Ajinomoto Pharmaceuticals, giving the Japan-based company the rights to further develop the drug and market it throughout Asia.. }
Showing items 1 to 1 of
1
with 100 items per page.
- Elobixibat abstract "Elobixibat is an IBAT inhibitor, in clinical testing as of December 2012 for the treatment of chronic constipation and irritable bowel syndrome with constipation (IBS-C). It works by blocking the enterohepatic circulation of bile acids, increasing the bile acid concentration in the gut, which accelerates intestinal passage and softens the stool.The drug was developed by Albireo AB, who licensed it to Ferring Pharmaceuticals for further development and marketing.Albireo has partnered with Ajinomoto Pharmaceuticals, giving the Japan-based company the rights to further develop the drug and market it throughout Asia.".